Gravide kvinder må kun behandles med CANCIDAS hvis det skønnes, at fordelene opvejer den mulige risiko for fostret.
CANCIDAS has not been studied in pregnant women, and should be used in pregnancy only if the potential benefit justifies the potential risk to the foetus.